Last update 14 Oct 2026

KMV-002

Overview

Basic Info

Drug Type
Therapeutic vaccine
Synonyms
IPT-PAP, KMV 002, KMV002
Target-
Action-
Mechanism-
Therapeutic Areas
NeoplasmsUrogenital Diseases
Active Indication
Metastatic castration-resistant prostate cancer
Inactive Indication-
Originator Organization
Kemi Biopharmaceuticals (Chengdu) Co., Ltd.Kemi Biopharmaceuticals (Chengdu) Co., Ltd.
Active Organization
Kemi Biopharmaceuticals (Chengdu) Co., Ltd.Kemi Biopharmaceuticals (Chengdu) Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with KMV-002
NCT07866300
/ Not yet recruitingPhase 1
A Phase I, Open-label, Dose-escalation and Dose-expansion Study of KMV002 in Patients With Metastatic Androgen Pathway Modulation-Resistant (mAPMR) Prostate Cancer
ChiCTR2600126657
/ Not yet recruitingNot ApplicableIIT
An Early Exploratory Clinical Study Protocol to Evaluate the Safety, Tolerability and Immunogenicity of KMV002 in Patients with Metastatic Androgen Pathway Modulator-Resistant Prostate Cancer (mAPMR)
100 Clinical Results associated with KMV-002
Login to view more data
100 Translational Medicine associated with KMV-002
Login to view more data
100 Patents (Medical) associated with KMV-002
Login to view more data
100 Deals associated with KMV-002
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Metastatic castration-resistant prostate cancerPhase 1
Australia
Kemi Biopharmaceuticals (Chengdu) Co., Ltd.Kemi Biopharmaceuticals (Chengdu) Co., Ltd.
01 Nov 2026
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free